nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR2B—Sorafenib—kidney cancer	0.0864	0.164	CbGbCtD
Pergolide—KCNH2—Sunitinib—kidney cancer	0.0581	0.11	CbGbCtD
Pergolide—HTR2C—Sorafenib—kidney cancer	0.0562	0.107	CbGbCtD
Pergolide—CYP2D6—Temsirolimus—kidney cancer	0.0553	0.105	CbGbCtD
Pergolide—CYP3A4—Everolimus—kidney cancer	0.0521	0.0987	CbGbCtD
Pergolide—CYP3A4—Temsirolimus—kidney cancer	0.0352	0.0667	CbGbCtD
Pergolide—CYP2D6—Pazopanib—kidney cancer	0.0291	0.0551	CbGbCtD
Pergolide—CYP2D6—Erlotinib—kidney cancer	0.0207	0.0393	CbGbCtD
Pergolide—CYP3A4—Pazopanib—kidney cancer	0.0185	0.035	CbGbCtD
Pergolide—CYP2D6—Sorafenib—kidney cancer	0.0169	0.032	CbGbCtD
Pergolide—CYP2D6—Vinblastine—kidney cancer	0.0166	0.0316	CbGbCtD
Pergolide—CYP3A4—Erlotinib—kidney cancer	0.0132	0.025	CbGbCtD
Pergolide—CYP3A4—Paclitaxel—kidney cancer	0.0121	0.0229	CbGbCtD
Pergolide—CYP3A4—Sorafenib—kidney cancer	0.0107	0.0203	CbGbCtD
Pergolide—CYP3A4—Vinblastine—kidney cancer	0.0106	0.0201	CbGbCtD
Pergolide—CYP3A4—Vincristine—kidney cancer	0.0104	0.0197	CbGbCtD
Pergolide—CYP2D6—Doxorubicin—kidney cancer	0.0102	0.0194	CbGbCtD
Pergolide—CYP3A4—Sunitinib—kidney cancer	0.00869	0.0165	CbGbCtD
Pergolide—CYP3A4—Doxorubicin—kidney cancer	0.0065	0.0123	CbGbCtD
Pergolide—HTR2A—urine—kidney cancer	0.000376	0.0935	CbGeAlD
Pergolide—CYP3A4—urine—kidney cancer	0.000348	0.0866	CbGeAlD
Pergolide—CYP2D6—urine—kidney cancer	0.000343	0.0852	CbGeAlD
Pergolide—ADRA1B—renal system—kidney cancer	0.000254	0.063	CbGeAlD
Pergolide—ADRA1B—kidney—kidney cancer	0.000245	0.0609	CbGeAlD
Pergolide—HTR1D—kidney—kidney cancer	0.000179	0.0445	CbGeAlD
Pergolide—HTR2B—cortex of kidney—kidney cancer	0.000162	0.0403	CbGeAlD
Pergolide—HTR1A—renal system—kidney cancer	0.000155	0.0384	CbGeAlD
Pergolide—ADRA2C—nephron tubule—kidney cancer	0.000149	0.0371	CbGeAlD
Pergolide—ADRA1A—renal system—kidney cancer	0.000142	0.0354	CbGeAlD
Pergolide—Headache—Erlotinib—kidney cancer	0.000139	0.00033	CcSEcCtD
Pergolide—Tinnitus—Capecitabine—kidney cancer	0.000139	0.00033	CcSEcCtD
Pergolide—Loss of consciousness—Paclitaxel—kidney cancer	0.000139	0.00033	CcSEcCtD
Pergolide—Pain—Vincristine—kidney cancer	0.000139	0.00033	CcSEcCtD
Pergolide—Constipation—Vincristine—kidney cancer	0.000139	0.00033	CcSEcCtD
Pergolide—Diplopia—Doxorubicin—kidney cancer	0.000139	0.00033	CcSEcCtD
Pergolide—Paraesthesia—Gemcitabine—kidney cancer	0.000139	0.000329	CcSEcCtD
Pergolide—Cough—Paclitaxel—kidney cancer	0.000138	0.000328	CcSEcCtD
Pergolide—Asthenia—Sunitinib—kidney cancer	0.000138	0.000328	CcSEcCtD
Pergolide—Dyspnoea—Gemcitabine—kidney cancer	0.000138	0.000327	CcSEcCtD
Pergolide—KCNH2—renal system—kidney cancer	0.000138	0.0342	CbGeAlD
Pergolide—Nausea—Vinblastine—kidney cancer	0.000137	0.000326	CcSEcCtD
Pergolide—Somnolence—Gemcitabine—kidney cancer	0.000137	0.000326	CcSEcCtD
Pergolide—Convulsion—Paclitaxel—kidney cancer	0.000137	0.000326	CcSEcCtD
Pergolide—Affect lability—Doxorubicin—kidney cancer	0.000137	0.000325	CcSEcCtD
Pergolide—Migraine—Doxorubicin—kidney cancer	0.000137	0.000325	CcSEcCtD
Pergolide—Nausea—Everolimus—kidney cancer	0.000137	0.000325	CcSEcCtD
Pergolide—Diarrhoea—Sorafenib—kidney cancer	0.000137	0.000325	CcSEcCtD
Pergolide—Hypertension—Paclitaxel—kidney cancer	0.000137	0.000325	CcSEcCtD
Pergolide—Pruritus—Sunitinib—kidney cancer	0.000136	0.000323	CcSEcCtD
Pergolide—ADRA2C—renal system—kidney cancer	0.000136	0.0337	CbGeAlD
Pergolide—Chest pain—Paclitaxel—kidney cancer	0.000135	0.00032	CcSEcCtD
Pergolide—Arthralgia—Paclitaxel—kidney cancer	0.000135	0.00032	CcSEcCtD
Pergolide—Myalgia—Paclitaxel—kidney cancer	0.000135	0.00032	CcSEcCtD
Pergolide—Anxiety—Paclitaxel—kidney cancer	0.000135	0.000319	CcSEcCtD
Pergolide—Face oedema—Doxorubicin—kidney cancer	0.000134	0.000319	CcSEcCtD
Pergolide—Decreased appetite—Gemcitabine—kidney cancer	0.000134	0.000319	CcSEcCtD
Pergolide—Chills—Capecitabine—kidney cancer	0.000134	0.000318	CcSEcCtD
Pergolide—Arrhythmia—Capecitabine—kidney cancer	0.000134	0.000317	CcSEcCtD
Pergolide—Discomfort—Paclitaxel—kidney cancer	0.000133	0.000316	CcSEcCtD
Pergolide—Gastrointestinal pain—Vincristine—kidney cancer	0.000133	0.000316	CcSEcCtD
Pergolide—Cardiac arrest—Doxorubicin—kidney cancer	0.000132	0.000314	CcSEcCtD
Pergolide—Dizziness—Sorafenib—kidney cancer	0.000132	0.000314	CcSEcCtD
Pergolide—Constipation—Gemcitabine—kidney cancer	0.000132	0.000313	CcSEcCtD
Pergolide—Pain—Gemcitabine—kidney cancer	0.000132	0.000313	CcSEcCtD
Pergolide—Nausea—Erlotinib—kidney cancer	0.000132	0.000313	CcSEcCtD
Pergolide—Alopecia—Capecitabine—kidney cancer	0.000132	0.000313	CcSEcCtD
Pergolide—Dry mouth—Paclitaxel—kidney cancer	0.000132	0.000313	CcSEcCtD
Pergolide—Mood swings—Doxorubicin—kidney cancer	0.000132	0.000313	CcSEcCtD
Pergolide—Diarrhoea—Sunitinib—kidney cancer	0.000132	0.000312	CcSEcCtD
Pergolide—ADRA2C—kidney—kidney cancer	0.000131	0.0326	CbGeAlD
Pergolide—Ataxia—Doxorubicin—kidney cancer	0.000131	0.00031	CcSEcCtD
Pergolide—Asthenia—Dactinomycin—kidney cancer	0.000131	0.00031	CcSEcCtD
Pergolide—Confusional state—Paclitaxel—kidney cancer	0.00013	0.000309	CcSEcCtD
Pergolide—Dehydration—Doxorubicin—kidney cancer	0.00013	0.000307	CcSEcCtD
Pergolide—Oedema—Paclitaxel—kidney cancer	0.000129	0.000307	CcSEcCtD
Pergolide—Abdominal pain—Vincristine—kidney cancer	0.000129	0.000305	CcSEcCtD
Pergolide—Body temperature increased—Vincristine—kidney cancer	0.000129	0.000305	CcSEcCtD
Pergolide—Liver function test abnormal—Doxorubicin—kidney cancer	0.000129	0.000305	CcSEcCtD
Pergolide—Infection—Paclitaxel—kidney cancer	0.000129	0.000305	CcSEcCtD
Pergolide—Flatulence—Capecitabine—kidney cancer	0.000128	0.000304	CcSEcCtD
Pergolide—ADRA2C—cortex of kidney—kidney cancer	0.000128	0.0318	CbGeAlD
Pergolide—Dry skin—Doxorubicin—kidney cancer	0.000128	0.000303	CcSEcCtD
Pergolide—Dysgeusia—Capecitabine—kidney cancer	0.000127	0.000302	CcSEcCtD
Pergolide—Dizziness—Sunitinib—kidney cancer	0.000127	0.000302	CcSEcCtD
Pergolide—Feeling abnormal—Gemcitabine—kidney cancer	0.000127	0.000302	CcSEcCtD
Pergolide—Shock—Paclitaxel—kidney cancer	0.000127	0.000302	CcSEcCtD
Pergolide—Vomiting—Sorafenib—kidney cancer	0.000127	0.000302	CcSEcCtD
Pergolide—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000127	0.000302	CcSEcCtD
Pergolide—Hypokalaemia—Doxorubicin—kidney cancer	0.000127	0.000301	CcSEcCtD
Pergolide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000127	0.0003	CcSEcCtD
Pergolide—Tachycardia—Paclitaxel—kidney cancer	0.000126	0.000299	CcSEcCtD
Pergolide—Rash—Sorafenib—kidney cancer	0.000126	0.000299	CcSEcCtD
Pergolide—Dermatitis—Sorafenib—kidney cancer	0.000126	0.000299	CcSEcCtD
Pergolide—Back pain—Capecitabine—kidney cancer	0.000126	0.000298	CcSEcCtD
Pergolide—Headache—Sorafenib—kidney cancer	0.000125	0.000297	CcSEcCtD
Pergolide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000125	0.000297	CcSEcCtD
Pergolide—Diarrhoea—Dactinomycin—kidney cancer	0.000125	0.000296	CcSEcCtD
Pergolide—Anorexia—Paclitaxel—kidney cancer	0.000123	0.000292	CcSEcCtD
Pergolide—Gastritis—Doxorubicin—kidney cancer	0.000123	0.000292	CcSEcCtD
Pergolide—KCNH2—cardiac atrium—kidney cancer	0.000123	0.0306	CbGeAlD
Pergolide—Vomiting—Sunitinib—kidney cancer	0.000122	0.00029	CcSEcCtD
Pergolide—Body temperature increased—Gemcitabine—kidney cancer	0.000122	0.00029	CcSEcCtD
Pergolide—Tremor—Capecitabine—kidney cancer	0.000122	0.000289	CcSEcCtD
Pergolide—ADRA2C—cardiac atrium—kidney cancer	0.000122	0.0302	CbGeAlD
Pergolide—Rash—Sunitinib—kidney cancer	0.000121	0.000288	CcSEcCtD
Pergolide—Dermatitis—Sunitinib—kidney cancer	0.000121	0.000288	CcSEcCtD
Pergolide—Abdominal distension—Doxorubicin—kidney cancer	0.000121	0.000287	CcSEcCtD
Pergolide—Hypotension—Paclitaxel—kidney cancer	0.000121	0.000287	CcSEcCtD
Pergolide—Ill-defined disorder—Capecitabine—kidney cancer	0.000121	0.000286	CcSEcCtD
Pergolide—Headache—Sunitinib—kidney cancer	0.000121	0.000286	CcSEcCtD
Pergolide—Influenza—Doxorubicin—kidney cancer	0.00012	0.000285	CcSEcCtD
Pergolide—Asthma—Doxorubicin—kidney cancer	0.00012	0.000285	CcSEcCtD
Pergolide—Dysphagia—Doxorubicin—kidney cancer	0.00012	0.000285	CcSEcCtD
Pergolide—Anaemia—Capecitabine—kidney cancer	0.00012	0.000285	CcSEcCtD
Pergolide—Eosinophilia—Doxorubicin—kidney cancer	0.000119	0.000283	CcSEcCtD
Pergolide—Nausea—Sorafenib—kidney cancer	0.000119	0.000282	CcSEcCtD
Pergolide—Pancreatitis—Doxorubicin—kidney cancer	0.000118	0.00028	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000118	0.00028	CcSEcCtD
Pergolide—Malaise—Capecitabine—kidney cancer	0.000117	0.000278	CcSEcCtD
Pergolide—Angina pectoris—Doxorubicin—kidney cancer	0.000117	0.000278	CcSEcCtD
Pergolide—Insomnia—Paclitaxel—kidney cancer	0.000117	0.000277	CcSEcCtD
Pergolide—Vertigo—Capecitabine—kidney cancer	0.000117	0.000277	CcSEcCtD
Pergolide—Asthenia—Vincristine—kidney cancer	0.000117	0.000277	CcSEcCtD
Pergolide—Syncope—Capecitabine—kidney cancer	0.000117	0.000277	CcSEcCtD
Pergolide—Leukopenia—Capecitabine—kidney cancer	0.000116	0.000276	CcSEcCtD
Pergolide—Paraesthesia—Paclitaxel—kidney cancer	0.000116	0.000275	CcSEcCtD
Pergolide—Vomiting—Dactinomycin—kidney cancer	0.000116	0.000275	CcSEcCtD
Pergolide—Bronchitis—Doxorubicin—kidney cancer	0.000116	0.000274	CcSEcCtD
Pergolide—Dyspnoea—Paclitaxel—kidney cancer	0.000115	0.000274	CcSEcCtD
Pergolide—Somnolence—Paclitaxel—kidney cancer	0.000115	0.000273	CcSEcCtD
Pergolide—Palpitations—Capecitabine—kidney cancer	0.000115	0.000273	CcSEcCtD
Pergolide—Rash—Dactinomycin—kidney cancer	0.000115	0.000273	CcSEcCtD
Pergolide—Nausea—Sunitinib—kidney cancer	0.000114	0.000271	CcSEcCtD
Pergolide—Loss of consciousness—Capecitabine—kidney cancer	0.000114	0.000271	CcSEcCtD
Pergolide—Dyspepsia—Paclitaxel—kidney cancer	0.000114	0.00027	CcSEcCtD
Pergolide—Cough—Capecitabine—kidney cancer	0.000114	0.000269	CcSEcCtD
Pergolide—Dysuria—Doxorubicin—kidney cancer	0.000113	0.000267	CcSEcCtD
Pergolide—Decreased appetite—Paclitaxel—kidney cancer	0.000112	0.000267	CcSEcCtD
Pergolide—Hypertension—Capecitabine—kidney cancer	0.000112	0.000266	CcSEcCtD
Pergolide—Diarrhoea—Vincristine—kidney cancer	0.000111	0.000264	CcSEcCtD
Pergolide—Pollakiuria—Doxorubicin—kidney cancer	0.000111	0.000264	CcSEcCtD
Pergolide—Asthenia—Gemcitabine—kidney cancer	0.000111	0.000263	CcSEcCtD
Pergolide—Myalgia—Capecitabine—kidney cancer	0.000111	0.000263	CcSEcCtD
Pergolide—Chest pain—Capecitabine—kidney cancer	0.000111	0.000263	CcSEcCtD
Pergolide—Arthralgia—Capecitabine—kidney cancer	0.000111	0.000263	CcSEcCtD
Pergolide—Constipation—Paclitaxel—kidney cancer	0.000111	0.000262	CcSEcCtD
Pergolide—Pain—Paclitaxel—kidney cancer	0.000111	0.000262	CcSEcCtD
Pergolide—Anxiety—Capecitabine—kidney cancer	0.00011	0.000262	CcSEcCtD
Pergolide—Weight increased—Doxorubicin—kidney cancer	0.00011	0.00026	CcSEcCtD
Pergolide—Discomfort—Capecitabine—kidney cancer	0.000109	0.000259	CcSEcCtD
Pergolide—Pruritus—Gemcitabine—kidney cancer	0.000109	0.000259	CcSEcCtD
Pergolide—Weight decreased—Doxorubicin—kidney cancer	0.000109	0.000258	CcSEcCtD
Pergolide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000109	0.000257	CcSEcCtD
Pergolide—Dry mouth—Capecitabine—kidney cancer	0.000108	0.000257	CcSEcCtD
Pergolide—Nausea—Dactinomycin—kidney cancer	0.000108	0.000257	CcSEcCtD
Pergolide—Pneumonia—Doxorubicin—kidney cancer	0.000108	0.000256	CcSEcCtD
Pergolide—Dizziness—Vincristine—kidney cancer	0.000108	0.000255	CcSEcCtD
Pergolide—Confusional state—Capecitabine—kidney cancer	0.000107	0.000254	CcSEcCtD
Pergolide—Feeling abnormal—Paclitaxel—kidney cancer	0.000107	0.000253	CcSEcCtD
Pergolide—Oedema—Capecitabine—kidney cancer	0.000106	0.000252	CcSEcCtD
Pergolide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000106	0.000251	CcSEcCtD
Pergolide—Diarrhoea—Gemcitabine—kidney cancer	0.000106	0.000251	CcSEcCtD
Pergolide—Renal failure—Doxorubicin—kidney cancer	0.000105	0.00025	CcSEcCtD
Pergolide—Infection—Capecitabine—kidney cancer	0.000105	0.00025	CcSEcCtD
Pergolide—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000105	0.000249	CcSEcCtD
Pergolide—Jaundice—Doxorubicin—kidney cancer	0.000105	0.000248	CcSEcCtD
Pergolide—Shock—Capecitabine—kidney cancer	0.000104	0.000248	CcSEcCtD
Pergolide—Conjunctivitis—Doxorubicin—kidney cancer	0.000104	0.000247	CcSEcCtD
Pergolide—Urinary tract infection—Doxorubicin—kidney cancer	0.000104	0.000247	CcSEcCtD
Pergolide—Thrombocytopenia—Capecitabine—kidney cancer	0.000104	0.000247	CcSEcCtD
Pergolide—Tachycardia—Capecitabine—kidney cancer	0.000104	0.000246	CcSEcCtD
Pergolide—Vomiting—Vincristine—kidney cancer	0.000104	0.000246	CcSEcCtD
Pergolide—Sweating—Doxorubicin—kidney cancer	0.000103	0.000244	CcSEcCtD
Pergolide—Rash—Vincristine—kidney cancer	0.000103	0.000244	CcSEcCtD
Pergolide—Hyperhidrosis—Capecitabine—kidney cancer	0.000103	0.000243	CcSEcCtD
Pergolide—Dermatitis—Vincristine—kidney cancer	0.000103	0.000243	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—kidney cancer	0.000102	0.000243	CcSEcCtD
Pergolide—Abdominal pain—Paclitaxel—kidney cancer	0.000102	0.000243	CcSEcCtD
Pergolide—Body temperature increased—Paclitaxel—kidney cancer	0.000102	0.000243	CcSEcCtD
Pergolide—Headache—Vincristine—kidney cancer	0.000102	0.000242	CcSEcCtD
Pergolide—ADRA2A—cortex of kidney—kidney cancer	0.000102	0.0253	CbGeAlD
Pergolide—Epistaxis—Doxorubicin—kidney cancer	0.000101	0.00024	CcSEcCtD
Pergolide—Anorexia—Capecitabine—kidney cancer	0.000101	0.00024	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—kidney cancer	0.000101	0.000239	CcSEcCtD
Pergolide—Hypotension—Capecitabine—kidney cancer	9.92e-05	0.000235	CcSEcCtD
Pergolide—Vomiting—Gemcitabine—kidney cancer	9.83e-05	0.000233	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—kidney cancer	9.81e-05	0.000233	CcSEcCtD
Pergolide—Rash—Gemcitabine—kidney cancer	9.74e-05	0.000231	CcSEcCtD
Pergolide—Dermatitis—Gemcitabine—kidney cancer	9.74e-05	0.000231	CcSEcCtD
Pergolide—ADRA2A—gonad—kidney cancer	9.71e-05	0.0241	CbGeAlD
Pergolide—ADRA2A—cardiac atrium—kidney cancer	9.7e-05	0.0241	CbGeAlD
Pergolide—Headache—Gemcitabine—kidney cancer	9.68e-05	0.00023	CcSEcCtD
Pergolide—Nausea—Vincristine—kidney cancer	9.68e-05	0.000229	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.67e-05	0.000229	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—kidney cancer	9.66e-05	0.000229	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—kidney cancer	9.63e-05	0.000228	CcSEcCtD
Pergolide—Insomnia—Capecitabine—kidney cancer	9.6e-05	0.000228	CcSEcCtD
Pergolide—Pharyngitis—Doxorubicin—kidney cancer	9.56e-05	0.000227	CcSEcCtD
Pergolide—Paraesthesia—Capecitabine—kidney cancer	9.53e-05	0.000226	CcSEcCtD
Pergolide—Oedema peripheral—Doxorubicin—kidney cancer	9.49e-05	0.000225	CcSEcCtD
Pergolide—Dyspnoea—Capecitabine—kidney cancer	9.47e-05	0.000224	CcSEcCtD
Pergolide—Dyspepsia—Capecitabine—kidney cancer	9.35e-05	0.000222	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—kidney cancer	9.28e-05	0.00022	CcSEcCtD
Pergolide—Asthenia—Paclitaxel—kidney cancer	9.28e-05	0.00022	CcSEcCtD
Pergolide—Decreased appetite—Capecitabine—kidney cancer	9.23e-05	0.000219	CcSEcCtD
Pergolide—HTR2A—renal system—kidney cancer	9.21e-05	0.0229	CbGeAlD
Pergolide—Nausea—Gemcitabine—kidney cancer	9.18e-05	0.000218	CcSEcCtD
Pergolide—Pruritus—Paclitaxel—kidney cancer	9.15e-05	0.000217	CcSEcCtD
Pergolide—Constipation—Capecitabine—kidney cancer	9.08e-05	0.000215	CcSEcCtD
Pergolide—Pain—Capecitabine—kidney cancer	9.08e-05	0.000215	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—kidney cancer	9e-05	0.000213	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—kidney cancer	8.98e-05	0.000213	CcSEcCtD
Pergolide—HTR2A—kidney—kidney cancer	8.9e-05	0.0221	CbGeAlD
Pergolide—Diarrhoea—Paclitaxel—kidney cancer	8.85e-05	0.00021	CcSEcCtD
Pergolide—Feeling abnormal—Capecitabine—kidney cancer	8.75e-05	0.000207	CcSEcCtD
Pergolide—Gastrointestinal pain—Capecitabine—kidney cancer	8.68e-05	0.000206	CcSEcCtD
Pergolide—Chills—Doxorubicin—kidney cancer	8.64e-05	0.000205	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—kidney cancer	8.61e-05	0.000204	CcSEcCtD
Pergolide—Dizziness—Paclitaxel—kidney cancer	8.56e-05	0.000203	CcSEcCtD
Pergolide—CYP3A4—renal system—kidney cancer	8.52e-05	0.0212	CbGeAlD
Pergolide—Alopecia—Doxorubicin—kidney cancer	8.51e-05	0.000202	CcSEcCtD
Pergolide—Abdominal pain—Capecitabine—kidney cancer	8.39e-05	0.000199	CcSEcCtD
Pergolide—Body temperature increased—Capecitabine—kidney cancer	8.39e-05	0.000199	CcSEcCtD
Pergolide—CYP2D6—renal system—kidney cancer	8.39e-05	0.0208	CbGeAlD
Pergolide—Flatulence—Doxorubicin—kidney cancer	8.26e-05	0.000196	CcSEcCtD
Pergolide—HTR2A—gonad—kidney cancer	8.26e-05	0.0205	CbGeAlD
Pergolide—CYP3A4—kidney—kidney cancer	8.24e-05	0.0205	CbGeAlD
Pergolide—Tension—Doxorubicin—kidney cancer	8.23e-05	0.000195	CcSEcCtD
Pergolide—Vomiting—Paclitaxel—kidney cancer	8.23e-05	0.000195	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—kidney cancer	8.21e-05	0.000195	CcSEcCtD
Pergolide—Rash—Paclitaxel—kidney cancer	8.16e-05	0.000193	CcSEcCtD
Pergolide—Dermatitis—Paclitaxel—kidney cancer	8.15e-05	0.000193	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—kidney cancer	8.15e-05	0.000193	CcSEcCtD
Pergolide—Back pain—Doxorubicin—kidney cancer	8.11e-05	0.000192	CcSEcCtD
Pergolide—CYP2D6—kidney—kidney cancer	8.11e-05	0.0202	CbGeAlD
Pergolide—Headache—Paclitaxel—kidney cancer	8.11e-05	0.000192	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—kidney cancer	7.78e-05	0.000185	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—kidney cancer	7.75e-05	0.000184	CcSEcCtD
Pergolide—Agitation—Doxorubicin—kidney cancer	7.71e-05	0.000183	CcSEcCtD
Pergolide—Nausea—Paclitaxel—kidney cancer	7.69e-05	0.000182	CcSEcCtD
Pergolide—Asthenia—Capecitabine—kidney cancer	7.62e-05	0.000181	CcSEcCtD
Pergolide—Malaise—Doxorubicin—kidney cancer	7.56e-05	0.000179	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—kidney cancer	7.54e-05	0.000179	CcSEcCtD
Pergolide—Syncope—Doxorubicin—kidney cancer	7.52e-05	0.000178	CcSEcCtD
Pergolide—Pruritus—Capecitabine—kidney cancer	7.51e-05	0.000178	CcSEcCtD
Pergolide—Leukopenia—Doxorubicin—kidney cancer	7.51e-05	0.000178	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—kidney cancer	7.41e-05	0.000176	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—kidney cancer	7.37e-05	0.000175	CcSEcCtD
Pergolide—Cough—Doxorubicin—kidney cancer	7.32e-05	0.000174	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—kidney cancer	7.27e-05	0.000172	CcSEcCtD
Pergolide—Diarrhoea—Capecitabine—kidney cancer	7.27e-05	0.000172	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—kidney cancer	7.24e-05	0.000172	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—kidney cancer	7.14e-05	0.000169	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—kidney cancer	7.14e-05	0.000169	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—kidney cancer	7.14e-05	0.000169	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—kidney cancer	7.12e-05	0.000169	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—kidney cancer	7.05e-05	0.000167	CcSEcCtD
Pergolide—Dizziness—Capecitabine—kidney cancer	7.02e-05	0.000166	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—kidney cancer	6.98e-05	0.000166	CcSEcCtD
Pergolide—Confusional state—Doxorubicin—kidney cancer	6.9e-05	0.000164	CcSEcCtD
Pergolide—Oedema—Doxorubicin—kidney cancer	6.84e-05	0.000162	CcSEcCtD
Pergolide—Infection—Doxorubicin—kidney cancer	6.8e-05	0.000161	CcSEcCtD
Pergolide—Vomiting—Capecitabine—kidney cancer	6.75e-05	0.00016	CcSEcCtD
Pergolide—Shock—Doxorubicin—kidney cancer	6.73e-05	0.00016	CcSEcCtD
Pergolide—Thrombocytopenia—Doxorubicin—kidney cancer	6.7e-05	0.000159	CcSEcCtD
Pergolide—Rash—Capecitabine—kidney cancer	6.7e-05	0.000159	CcSEcCtD
Pergolide—Dermatitis—Capecitabine—kidney cancer	6.69e-05	0.000159	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—kidney cancer	6.68e-05	0.000158	CcSEcCtD
Pergolide—Headache—Capecitabine—kidney cancer	6.65e-05	0.000158	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—kidney cancer	6.62e-05	0.000157	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—kidney cancer	6.52e-05	0.000155	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—kidney cancer	6.4e-05	0.000152	CcSEcCtD
Pergolide—Nausea—Capecitabine—kidney cancer	6.31e-05	0.00015	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.24e-05	0.000148	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—kidney cancer	6.19e-05	0.000147	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—kidney cancer	6.15e-05	0.000146	CcSEcCtD
Pergolide—Dyspnoea—Doxorubicin—kidney cancer	6.1e-05	0.000145	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—kidney cancer	6.08e-05	0.000144	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—kidney cancer	6.03e-05	0.000143	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—kidney cancer	5.95e-05	0.000141	CcSEcCtD
Pergolide—Pain—Doxorubicin—kidney cancer	5.85e-05	0.000139	CcSEcCtD
Pergolide—Constipation—Doxorubicin—kidney cancer	5.85e-05	0.000139	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—kidney cancer	5.64e-05	0.000134	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—kidney cancer	5.6e-05	0.000133	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—kidney cancer	5.41e-05	0.000128	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—kidney cancer	5.41e-05	0.000128	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—kidney cancer	4.91e-05	0.000116	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—kidney cancer	4.84e-05	0.000115	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—kidney cancer	4.68e-05	0.000111	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—kidney cancer	4.53e-05	0.000107	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—kidney cancer	4.35e-05	0.000103	CcSEcCtD
Pergolide—Rash—Doxorubicin—kidney cancer	4.32e-05	0.000102	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—kidney cancer	4.31e-05	0.000102	CcSEcCtD
Pergolide—Headache—Doxorubicin—kidney cancer	4.29e-05	0.000102	CcSEcCtD
Pergolide—Nausea—Doxorubicin—kidney cancer	4.07e-05	9.64e-05	CcSEcCtD
Pergolide—ADRA1D—Signaling Pathways—CCND1—kidney cancer	5.08e-06	0.000109	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CCND1—kidney cancer	5.08e-06	0.000109	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—PIK3CA—kidney cancer	5.08e-06	0.000109	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KIT—kidney cancer	5.07e-06	0.000108	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—APC—kidney cancer	5.07e-06	0.000108	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—JUN—kidney cancer	5.07e-06	0.000108	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—JUN—kidney cancer	5.07e-06	0.000108	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—kidney cancer	5.07e-06	0.000108	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RAF1—kidney cancer	5.07e-06	0.000108	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.05e-06	0.000108	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RELA—kidney cancer	5.04e-06	0.000108	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RAF1—kidney cancer	5.04e-06	0.000108	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CTNNB1—kidney cancer	5.03e-06	0.000108	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	5.03e-06	0.000108	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PSMD7—kidney cancer	5.02e-06	0.000107	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RELA—kidney cancer	5.02e-06	0.000107	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ERBB2—kidney cancer	5.01e-06	0.000107	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—kidney cancer	4.99e-06	0.000107	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ERBB2—kidney cancer	4.99e-06	0.000107	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	4.98e-06	0.000106	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PTEN—kidney cancer	4.97e-06	0.000106	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MTOR—kidney cancer	4.95e-06	0.000106	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PTEN—kidney cancer	4.95e-06	0.000106	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—PIK3CA—kidney cancer	4.94e-06	0.000106	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	4.93e-06	0.000105	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MTOR—kidney cancer	4.92e-06	0.000105	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PTEN—kidney cancer	4.9e-06	0.000105	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PTEN—kidney cancer	4.9e-06	0.000105	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RAF1—kidney cancer	4.9e-06	0.000105	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MAPK3—kidney cancer	4.9e-06	0.000105	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RELA—kidney cancer	4.88e-06	0.000104	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—KRAS—kidney cancer	4.88e-06	0.000104	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	4.86e-06	0.000104	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	4.86e-06	0.000104	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.86e-06	0.000104	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	4.85e-06	0.000104	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—POMC—kidney cancer	4.83e-06	0.000103	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RAF1—kidney cancer	4.82e-06	0.000103	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	4.81e-06	0.000103	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RELA—kidney cancer	4.8e-06	0.000103	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—KRAS—kidney cancer	4.8e-06	0.000103	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MAPK3—kidney cancer	4.79e-06	0.000102	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MTOR—kidney cancer	4.79e-06	0.000102	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	4.77e-06	0.000102	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—BRAF—kidney cancer	4.77e-06	0.000102	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MYC—kidney cancer	4.76e-06	0.000102	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—BCHE—kidney cancer	4.76e-06	0.000102	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—kidney cancer	4.76e-06	0.000102	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.75e-06	0.000102	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MAPK3—kidney cancer	4.72e-06	0.000101	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MTOR—kidney cancer	4.71e-06	0.000101	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL2—kidney cancer	4.71e-06	0.000101	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.7e-06	0.000101	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	4.7e-06	0.0001	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MYC—kidney cancer	4.66e-06	9.97e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MAPK1—kidney cancer	4.66e-06	9.96e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	4.64e-06	9.92e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	4.62e-06	9.88e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	4.62e-06	9.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—kidney cancer	4.61e-06	9.85e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MYC—kidney cancer	4.59e-06	9.81e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CCND1—kidney cancer	4.59e-06	9.81e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—JUN—kidney cancer	4.58e-06	9.79e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MAPK1—kidney cancer	4.56e-06	9.75e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	4.54e-06	9.71e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL2—kidney cancer	4.54e-06	9.71e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.54e-06	9.71e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL2—kidney cancer	4.52e-06	9.66e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MAPK3—kidney cancer	4.5e-06	9.63e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	4.49e-06	9.6e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—kidney cancer	4.49e-06	9.6e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MAPK1—kidney cancer	4.49e-06	9.6e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	4.48e-06	9.58e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RAF1—kidney cancer	4.45e-06	9.51e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—kidney cancer	4.43e-06	9.47e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	4.43e-06	9.47e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RELA—kidney cancer	4.43e-06	9.47e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCND1—kidney cancer	4.43e-06	9.47e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PTEN—kidney cancer	4.43e-06	9.46e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	4.42e-06	9.45e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—JUN—kidney cancer	4.42e-06	9.45e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	4.42e-06	9.44e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	4.41e-06	9.43e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCND1—kidney cancer	4.41e-06	9.42e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ERBB2—kidney cancer	4.4e-06	9.41e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—KRAS—kidney cancer	4.4e-06	9.41e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—JUN—kidney cancer	4.4e-06	9.4e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL2—kidney cancer	4.4e-06	9.4e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	4.39e-06	9.37e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—kidney cancer	4.38e-06	9.36e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RAF1—kidney cancer	4.38e-06	9.36e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	4.37e-06	9.33e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	4.36e-06	9.33e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RELA—kidney cancer	4.36e-06	9.31e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MTOR—kidney cancer	4.34e-06	9.28e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ERBB2—kidney cancer	4.33e-06	9.26e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL2—kidney cancer	4.33e-06	9.25e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	4.32e-06	9.23e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—KRAS—kidney cancer	4.31e-06	9.21e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RAF1—kidney cancer	4.29e-06	9.16e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MAPK1—kidney cancer	4.28e-06	9.16e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCND1—kidney cancer	4.28e-06	9.16e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—JUN—kidney cancer	4.28e-06	9.14e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PTEN—kidney cancer	4.27e-06	9.14e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MTOR—kidney cancer	4.27e-06	9.13e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RELA—kidney cancer	4.27e-06	9.12e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PTEN—kidney cancer	4.25e-06	9.09e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MAPK3—kidney cancer	4.25e-06	9.08e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	4.24e-06	9.07e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	4.24e-06	9.06e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—KRAS—kidney cancer	4.24e-06	9.06e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCND1—kidney cancer	4.22e-06	9.01e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—JUN—kidney cancer	4.21e-06	9e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	4.19e-06	8.96e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK3—kidney cancer	4.19e-06	8.96e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.18e-06	8.94e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	4.18e-06	8.93e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PTEN—kidney cancer	4.14e-06	8.84e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—kidney cancer	4.13e-06	8.83e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—kidney cancer	4.08e-06	8.71e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4.08e-06	8.71e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—kidney cancer	4.08e-06	8.71e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PTEN—kidney cancer	4.07e-06	8.7e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—KRAS—kidney cancer	4.05e-06	8.65e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	4.04e-06	8.64e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MAPK1—kidney cancer	4.04e-06	8.64e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTEN—kidney cancer	4.02e-06	8.59e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	4.01e-06	8.58e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	4.01e-06	8.57e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	4e-06	8.55e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL2—kidney cancer	3.99e-06	8.53e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	3.99e-06	8.52e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK1—kidney cancer	3.99e-06	8.52e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.98e-06	8.51e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.96e-06	8.47e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	3.96e-06	8.46e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	3.94e-06	8.42e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	3.93e-06	8.39e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL2—kidney cancer	3.92e-06	8.39e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—kidney cancer	3.91e-06	8.36e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PIK3CA—kidney cancer	3.89e-06	8.33e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCND1—kidney cancer	3.89e-06	8.31e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MTOR—kidney cancer	3.89e-06	8.31e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—JUN—kidney cancer	3.88e-06	8.29e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—kidney cancer	3.86e-06	8.25e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CTNNB1—kidney cancer	3.85e-06	8.23e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL2—kidney cancer	3.84e-06	8.21e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—kidney cancer	3.84e-06	8.21e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—kidney cancer	3.83e-06	8.19e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCND1—kidney cancer	3.83e-06	8.18e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—JUN—kidney cancer	3.82e-06	8.16e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—KRAS—kidney cancer	3.82e-06	8.16e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	3.79e-06	8.1e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—kidney cancer	3.79e-06	8.1e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	3.78e-06	8.09e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—kidney cancer	3.77e-06	8.05e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—KRAS—kidney cancer	3.77e-06	8.05e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—KRAS—kidney cancer	3.77e-06	8.05e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—POMC—kidney cancer	3.76e-06	8.05e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PTEN—kidney cancer	3.75e-06	8.02e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCND1—kidney cancer	3.75e-06	8.01e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—JUN—kidney cancer	3.74e-06	7.99e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	3.74e-06	7.99e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	3.72e-06	7.95e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	3.71e-06	7.93e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PTEN—kidney cancer	3.69e-06	7.89e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—kidney cancer	3.68e-06	7.87e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	3.68e-06	7.86e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK3—kidney cancer	3.65e-06	7.81e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	3.65e-06	7.8e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK3—kidney cancer	3.63e-06	7.77e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PTEN—kidney cancer	3.62e-06	7.73e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	3.6e-06	7.69e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—kidney cancer	3.6e-06	7.69e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ABCB1—kidney cancer	3.59e-06	7.67e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL2—kidney cancer	3.57e-06	7.63e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—kidney cancer	3.55e-06	7.59e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	3.53e-06	7.55e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—kidney cancer	3.53e-06	7.55e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PIK3CA—kidney cancer	3.51e-06	7.5e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PIK3CA—kidney cancer	3.49e-06	7.46e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTM1—kidney cancer	3.48e-06	7.44e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCND1—kidney cancer	3.48e-06	7.44e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	3.48e-06	7.43e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.47e-06	7.43e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.47e-06	7.42e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	3.46e-06	7.4e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PIK3CA—kidney cancer	3.46e-06	7.4e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.46e-06	7.39e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.45e-06	7.37e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—kidney cancer	3.44e-06	7.35e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—KRAS—kidney cancer	3.4e-06	7.27e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—kidney cancer	3.39e-06	7.25e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.39e-06	7.25e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—kidney cancer	3.38e-06	7.23e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	3.36e-06	7.19e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.36e-06	7.18e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—kidney cancer	3.35e-06	7.15e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—kidney cancer	3.35e-06	7.15e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.33e-06	7.13e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	3.31e-06	7.07e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.3e-06	7.05e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.28e-06	7.02e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.27e-06	6.98e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.26e-06	6.98e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.21e-06	6.85e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—KRAS—kidney cancer	3.18e-06	6.79e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.15e-06	6.74e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—KRAS—kidney cancer	3.13e-06	6.68e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	3.12e-06	6.68e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—kidney cancer	3.12e-06	6.67e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.09e-06	6.6e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—kidney cancer	3.07e-06	6.56e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK1—kidney cancer	3.05e-06	6.52e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	3.03e-06	6.49e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—kidney cancer	3.02e-06	6.46e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	3.02e-06	6.45e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—kidney cancer	3e-06	6.42e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3e-06	6.42e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—kidney cancer	3e-06	6.42e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	3e-06	6.41e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.94e-06	6.28e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.92e-06	6.24e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—kidney cancer	2.92e-06	6.24e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—kidney cancer	2.9e-06	6.2e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—KRAS—kidney cancer	2.88e-06	6.16e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.87e-06	6.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.87e-06	6.14e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.84e-06	6.06e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.83e-06	6.06e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.82e-06	6.03e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.79e-06	5.97e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.78e-06	5.94e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.78e-06	5.93e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.73e-06	5.84e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.65e-06	5.66e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTEN—kidney cancer	2.62e-06	5.6e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.6e-06	5.57e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.58e-06	5.51e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—kidney cancer	2.56e-06	5.47e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	2.55e-06	5.45e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—kidney cancer	2.52e-06	5.39e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.47e-06	5.27e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—POMC—kidney cancer	2.46e-06	5.26e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.37e-06	5.07e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.29e-06	4.9e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.96e-06	4.2e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.85e-06	3.95e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTEN—kidney cancer	1.71e-06	3.66e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.21e-06	2.58e-05	CbGpPWpGaD
